First Republic Investment Management, Inc. Kiniksa Pharmaceuticals, Ltd. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 14, 2021	SELL	$16.68 - $23.97 $244,645 - $351,567	-14,667 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $217,071 - $310,207	14,667 New	14,667 $259,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$32.3 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.31 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.08 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$840,656
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$638,700
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $734M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account